Showing results (1861-1870 of 8,963) with videos related to
Sort By:
Pageof 897
Journal of Hepatology|January 26, 2018
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammationNadine Gehrke, Nadine Hövelmeyer, Ari Waisman, et al.Journal of Hepatology|January 30, 2018
Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinomaJian Yu, Qing-Guo Xu, Zhen-Guang Wang, et al.Journal of Hepatology|November 23, 2017
Is cryptogenic cirrhosis different from NASH cirrhosis?Paul J Thuluvath, Sergey Kantsevoy, Avesh J Thuluvath, et al.Journal of Hepatology|January 15, 2018
Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signalingKateryna Levada, Nurdan Guldiken, Xiaoji Zhang, et al.Journal of Hepatology|January 1, 1985
HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitisK T Nouri-Aria, P T Donaldson, J E Hegarty, et al.Journal of Hepatology|December 24, 2017
Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020Nick Scott, Sigurður Ólafsson, Magnús Gottfreðsson, et al.Journal of Hepatology|February 10, 2018
Mesenchymal stromal cell therapy for liver diseasesMohammed Alfaifi, Young Woo Eom, Philip N Newsome, et al.Journal of Hepatology|January 1, 1986
Influence of sexual preference and chronic hepatitis B virus infection on T lymphocyte subsets, natural killer activity, and suppressor cell activityD M Novick, D J Brown, A S Lok, et al.Journal of Hepatology|March 6, 2018
The role of molecular enrichment on future therapies in hepatocellular carcinomaJean-Charles Nault, Peter R Galle, Jens U MarquardtJournal of Hepatology|March 9, 2018
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinomaJulia Chalaye, Charlotte E Costentin, Alain Luciani, et al.Pageof 897